MAP2 [HM-2]

HM-2

Rat brain microtubule associated proteins (MAPs).

Monoclonal Anti-MAP2 does not react with tubulin of other microtubule associated proteins.

MAP2

Lot specific and is stated on the vial Storage

For ICC: Use at an assay dependent dilution. For IHC (suitable): Use at an assay dependent dilution. For WB: Use at a concentration of 1-2 µ g/ml. Not tested in other applications. Optimal dilutions/concentrations should be determined by the researcher. MAP2 is the major microtubule associated protein of brain tissue. There are three forms of MAP2; two are similarily sized with apparent molecular weights of 280 kDa (MAP2a and MAP2b) and the third with a lower molecular weight of 70 kDa (MAP2c). In the newborn rat brain MAP2b and MAP2c are present while MAP2a is absent. Between postnatal days 10 and 20 MAP2a appears. At the same time the level of MAP2c drops by 10-fold. This change happens during the period when dendrite growth is completed and when neurons have reached their mature morphology. MAP2 is degraded by a Cathepsin D-like protease in the brain of aged rats. There is some indication that MAP2 is expressed at higher levels in some types of neurons than in other types. MAP2 is known to promote microtubule assembly and to form side-arms on microtubules. It also interacts with neurofilaments actin and other elements of the cytoskeleton.

Cytoplasm cytoskeleton (Probable).

Contains 3 Tau/MAP repeats.